Gene–Environment Interactions in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system in which both inherited susceptibility and environmental exposures contribute to disease risk. The article by Jacobs and colleagues, Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study, addresses a central question in MS epidemiology: whether genetic predisposition modifies the effects of known environmental risk factors. Rather than treating genetic and environmental risks as independent contributors, the study evaluates whether their combined influence may exceed what would be expected from either factor alone.
Study Design and Data Source
The investigators used UK Biobank, a large population-based biomedical cohort containing genetic, clinical, demographic, and lifestyle data. MS cases were identified through ICD-coded diagnoses, self-report, general practitioner records, and death registration, while controls were participants without an MS diagnosis. The final analysis included more than 2,250 individuals with MS and approximately 486,000 controls, providing substantial statistical power for evaluating both environmental risk factors and polygenic risk scores.
Environmental Risk Factors Examined
The authors focused on early-life and adolescent exposures to reduce the possibility that MS itself influenced the exposure measurements. These included childhood body size at age 10, smoking before age 20, age at menarche, birth weight, breastfeeding, maternal smoking, month of birth, infectious mononucleosis before age 20, age at first sexual intercourse, and male pubertal timing. Among these, childhood obesity, smoking before age 20, and earlier age at menarche showed statistically robust associations with MS risk in the UK Biobank cohort.
Polygenic Risk Scores and Genetic Architecture
To quantify inherited susceptibility, the study constructed polygenic risk scores using genetic variants identified in large MS genome-wide association studies. The authors created two categories of scores: one including the major histocompatibility complex region, known to contain the strongest MS-associated immune genes, and another excluding this region to test whether risk outside the HLA locus also mattered. Both polygenic scores were significantly associated with MS, supporting the view that MS risk reflects a broad polygenic architecture rather than dependence on a single genetic region.
Main Finding: Interaction Between Childhood Obesity and Genetic Risk
The most important finding was evidence of additive interaction between childhood body size and polygenic risk. In practical terms, individuals with both higher childhood body size and higher genetic susceptibility appeared to have a greater MS risk than would be expected from simply adding the separate effects of obesity and genetic predisposition. Crucially, this interaction remained evident even when the major histocompatibility complex region was excluded from the polygenic score, suggesting that non-HLA genetic variation may also modulate the effect of childhood obesity on MS susceptibility.
Biological Interpretation and Scientific Significance
The study contributes to a more nuanced model of MS pathogenesis. Childhood obesity is associated with systemic inflammation, altered adipokine signaling, metabolic dysregulation, and changes in immune function, all of which may plausibly interact with genetic variants influencing immune regulation. The finding that non-HLA polygenic risk interacts with childhood body size suggests that MS susceptibility may arise from distributed genetic effects that shape an individual’s biological response to environmental exposures. This supports a precision-prevention framework in which risk is not determined by environment or genetics alone, but by their interaction across development.
Limitations and Implications for Prevention
The authors appropriately emphasize that statistical interaction does not automatically prove direct biological interaction, and the findings require replication in independent cohorts. Additional limitations include retrospective self-report of childhood body size and smoking, possible misclassification of MS diagnosis, limited generalizability beyond predominantly White UK Biobank participants, and modest variance explained by the polygenic scores. Nevertheless, the study is important because it suggests that reducing childhood obesity may have particular relevance for individuals at elevated genetic risk of MS, and it provides a foundation for future research into genetically informed prevention strategies.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Breedon, J. R., Marshall, C. R., Giovannoni, G., van Heel, D. A., Dobson, R., & Jacobs, B. M. (2023). Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry. Brain Communications, 5(2), fcad041.
